# Stimulated Glucagon as a Biomarker of Hypoglycemic Risk in Type 1 Diabetes

> **NCT05616273** · — · COMPLETED · sponsor: **University of Exeter** · enrollment: 62 (actual)

## Conditions studied

- Type 1 Diabetes
- Hypoglycemia

## Interventions

- **OTHER:** Mixed Meal Tolerance Test (MMTT)
- **OTHER:** Arginine Stimulation Test (AST)
- **OTHER:** Home Finger Prick Sample

## Key facts

- **NCT ID:** NCT05616273
- **Lead sponsor:** University of Exeter
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-05-03
- **Primary completion:** 2025-01-28
- **Final completion:** 2025-09-30
- **Target enrollment:** 62 (ACTUAL)
- **Last updated:** 2025-12-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05616273

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05616273, "Stimulated Glucagon as a Biomarker of Hypoglycemic Risk in Type 1 Diabetes". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT05616273. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*